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Abstract
In this study, a phytochemical analysis was performed, for the first time, on Iris marsica I. Ricci e Colas. In 
particular, the attention was focused on the constituents of the roots. Twenty-one compounds were isolated by 
column chromatography and were analyzed/identified by NMR spectroscopy and mass spectrometry. They all own 
chemotaxonomic, ethno-pharmacological and nutraceutical relevance which allowed us to provide a phytochemical 
rationale, for the correct botanical classification of this species, for the employment of its roots in folk medicine like 
for all the other species belonging to the Iris genus and, lastly, for their further uses as food with important healthy 
benefits. All of these parts were broadly discussed about within the text.
Keywords: Iris marsica I. Ricci e Colas.; Roots; Phytochemical 
analysis; Chemotaxonomy; Ethno-pharmacology; Nutraceutics
Introduction
Iris marsica I. Ricci e Colas. is a rhizomatous perennial herbaceous 
plant belonging to the Iridaceae family. It is also known with the 
common name of Marsican Iris with the epithet Marsican deriving 
from latin and referring to its growth area i.e., Marsican Mountains 
located in Abruzzo, central Italy. From the botanical point of view, this 
species is characterized by a stem generally high 30-40 cm, with two 
branches of different length. It possesses rounded spathes at the base 
of the branches, with a slighty scarious acute apex. The leaves are light 
green colored, slightly glaucous, falcate, acute, growing about 30 cm 
in length. The flowers have a very slight fragrance and may be colored 
in different shades of violet. Three of them are usually uphold by the 
stem and the two branches, and they bloom from May to June. It also 
possesses a thick rhizome, compressed, rather knobby, branchy, which 
grows at ground level [1] (Figure 1).
Morphologically, I. marsica is very similar to I. germanica but the 
latter possesses persistent leaves, stems with 4-6 flowers, spathes which 
are scarious for 1/3-2/3 of their length, wider flower lacinies, sub-
globose red-brownish seeds while those of I. marsica are oval and light 
brown [2].
This species represents an important endemism to Central Italy 
where it only grows in the inner areas of Abruzzo, Latium, Marche 
and Umbria regions, on mountain dry pastures, between 1000 and 
1800 masl [3]. The studied sample was collected in the area of Majella 
National Park which represents a hot spot for biodiversity in central Italy 
with the presence of several endemic and rare species with restricted 
distribution [4-8] and peculiar secondary metabolites contents [9-11]. 
Endemic species present a peculiar genotype that leads to important 
phenotypic peculiarities, which may be recognized in their metabolic 
patterns, and which could be related to the evolution and adaption of 
the endemic species to the colonized environments [12].
I. marsica is a rare species included in the Red Lists of Plants at 
European [13], national [14] and regional [15] level as a species 
at risk of extinction, in the annex I of the Berna Convention and in 
the annex IV of the Habitat Directive. Several Iris species own a well 
known employment in the European traditional medicine due to 
their extraordinary pharmacological properties. These range from the 
important anti-cancer, anti-inflammatory, anti-bacterial and anti-viral 
[16] to the interesting emetic, diuretic, stimulant and expectorant ones 
[17] not to consider the pain-killer effect for teething children [17] and 
the anti-malarial activity [18].
Also in the Eastern nations of the world, the medicinal use of Iris 
species was established. For instance, this is very true in Iran where I. 
germanica extract is still employed as diuretic and expectorant as well 
Figure 1: Iris marsica I. Ricci e Colas.
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(Waters, Manchester, UK) equipped with an ESI source operating in the 
negative and/or positive ion mode. The flow rate of the sample infusion 
was 10 μl/min. with 50 acquisitions per spectrum. Data were analysed 
using the MassLynx software developed by Waters.
Extraction procedure
An aliquot of the whole plant material, weighing 420.0 g was 
inserted in a conical flask and fully covered with ethanol 96%. This was 
left closed for 48 hours in order to let primary and secondary metabolites 
come into solution. The solution, having a reddish coloration, was then 
filtered into one same round bottom flask and concentrated under 
reduced pressure at a temperature of about 50°C. A second extraction 
was performed for an exhaustive process but this time the solution 
utilized for this was a mixture of ethanol 96% and distilled water in ratio 
80/20 v/v. This step was necessary in order to also let the most polar 
components come into solution. Also this solution with a yellowish 
coloration was filtered and concentrated under reduced pressure at a 
temperature of about 50°C but in the same round bottom flask of the 
previous solution, thus having one total extract solution. During the 
concentration of the first solution, pH was checked on normal litmus 
paper in order to verify that this was not too acid meaning under the 
value of 5.5 on the pH scale. This step was absolutely necessary since 
a pH value below 5.5 pH units could cause unpleasant secondary 
reactions on the metabolites such as the hydrolysis of the glycosidic 
and/or ester groups which would not happen at higher pH values (6-8 
pH units), instead. Actually, this check gave a result of 6.5 on the pH 
scale. After concentration, the extract was lyophilized to obtain 25.9 g 
of orange-colored crude extract.
Isolation and identification of the metabolites
An aliquot of the total crude extract for the weight of 3.0 g was 
subjected to a first chromatographic separation procedure via classical 
column chromatography on silica gel. Its weight was 120.0 g (ratio 1:40) 
and the eluting system consisted of a solution of n-butanol and distilled 
water at concentration 82/18 (v/v). During the chromatographic run, 
the polarity of the eluting solution was raised in order to let the elution of 
the most polar compounds and so this became a solution of n-butanol, 
methanol and distilled water at concentration 70/10/30 (v/v/v). From 
this chromatographic separation, twelve compounds were identified: 
tristearoyl-sn-glycerol (1) and 1-margaroyl-2-lauroyl-3-palmitoyl-sn-
glycerol (2) [30] as a mixture in ratio 2:1 from the assembly of fractions 
1-5 for the total weight of 36.6 mg; nigricin 4'-O-β-D-glucopyranoside 
(10) [27] as almost pure compound from fraction 36 for the weight of 
135.8 mg; glucose (15) and phenylalanine (19) [31] as a mixture in ratio 
5:1 from the assembly of fractions 61-70 for the total weight of 81.4 mg; 
glucose (15), sucrose (16), raffinose (17), lactic acid (18), isoleucine 
(20) and valine (21) [31] in mixture (ratio not detectable) from the 
assembly of fractions 91-165 for the total weight of 217.2 mg.
Since not all compounds present were detected and identified, 
a second chromatographic separation was conducted on a specific 
assembly derived from the first chromatographic separation namely 
fractions 6-23 for the total weight of 308.9 mg. The correspective amount 
of silica gel was 12.0 g (ratio 1:40) and the eluting system was, this time, 
a mixture of chloroform and methanol at different concentrations. 
The initial one was 97/3 (v/v) but during the chromatographic run, 
this was changed in order to raise the polarity of the solution passing 
to 95/5 (v/v), 9/1 (v/v), 8/2 (v/v), 7/3 (v/v) and lastly, 6/4 (v/v). From 
this chromatographic separation seven compounds were identified: 
irigenin S (8) [25] in mixture with irisolidone (5) [17] in ratio 3:1 
from fraction 3 for the weight of 6.8 mg; nigricin (6) [32], irigenin (7) 
as to cure many diseases affecting liver, lungs and uteri and to treat 
hemorrhoids [19]. Yet this is also true in China where particular species 
of Iris are utilized to treat coughing and pharyngitis [20,21] and also to 
reduce inflammation and relieve respiratory disorders [22].
In literature, several works about phytochemistry of the Iris genus 
can be found, reporting the presence of several secondary metabolites 
such as steroids [23], terpenoids [24,25], flavonoids, xanthones, 
isoflavonoids [26,27] and anthocyanins [28]. On the other hand, a 
couple of studies have been performed in the past on phytochemistry 
of I. marsica evidencing the presence of particular flavonoids and 
xanthones [22,29].
This represents the main reason why this work was started in order 
to provide a much more general view on the total phytochemistry of 
this species. Moreover, the second aim of this work was to verify if also 
this species can be used in the ethno-pharmacological field just like all 
the other Iris species. These two elements will be verified according to 
the presence or not of specific secondary metabolites which may justify 
the employment of this species in these senses if they are endowed with 
very important medicinal or even nutraceutical properties.
Materials and Methods
Plant material
The plant material consisting of the only roots for the total weight 
of 450 g, was collected on the M. Pizzalto, in the municipality of 
Pescocostanzo – L’Aquila province (Central Italy) in August 2016 at an 
altitude of 1650 m a.s.l. The botanical classification was performed by 
the botanists of the same Park (Dr. Mirella di Cecco and Dr. Giampiero 
Ciaschetti) using available literature [1,2]. A sample of this collection is 
stored in our laboratory for further references under the voucher name 
IM0160408.
Chemicals
Throughout this study, the following reagents and solvents were 
utilized: ethanol 96% and distilled water as pure solvents or in mixture 
between them at the specific concentration of 80/20 v/v for the extraction 
procedure of the plant material; n-butanol, distilled water, methanol 
and chloroform as pure solvents or in mixture among them all at 
different concentrations to be used as eluting systems for the separation 
procedure via classical column chromatography; silica gel having 40-
63 μm particle size to be used as stationary phase for the separation 
procedure via classical column chromatography; sulfuric acid 2N for 
the development of TLCs; deuterated solvents such as CDCl3, CD3OD 
and D2O for the identification of the metabolites by NMR Spectroscopy; 
methanol with RS purity grade for the identification of the metabolites 
by Mass Spectrometry.
All the natural solvents and reagents having RPE analytical degree, 
if not otherwise specified, were purchased from “Carlo Erba Reagenti” 
or “Sigma Aldrich” as well as the deuterated solvents while silica gel was 
bought from “Fluka Analytical”.
Instrumentation
NMR spectra were recorded on a Varian Mercury 300 MHz 
instrument or on a Bruker 400 MHz instrument. The chemical shifts 
were expressed using the TMS signal at 0 ppm (s) as reference for the 
spectra in CDCl3. The internal solvent signal (m5) at 3.31 ppm was used 
as reference for the spectra recorded in CD3OD, instead. Lastly, the 
HDO signal (s) at 4.78 ppm was set as reference for spectra in D2O. MS 
spectra were, instead, performed on a Q-TOF MICRO spectrometer 
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irigenin S (8): 1H NMR (300 MHz, CDCl3) δ: 7.87 (1H, s, H-2), 
6.86 (1H, br s, H-2'), 6.70 (1H, d, J = 3.2 Hz, H-6'), 6.53 (1H, s, H-8), 
4.08 (3H, s, 7-OCH3), 4.04 (3H, s, 5'-OCH3), 3.93 (3H, s, 6-OCH3), 3.90 
(3H, s, 4'-OCH3). ESI-MS for C19H18O8: m/z = 413.29 [M+K]+ (calcd. 
413.4396 for C19H18KO8+)
irisflogenin (9): 1H NMR (300 MHz, CDCl3) δ: 7.90 (1H, s, H-2), 
7.41 (1H, dd, J = 8.4/4.1 Hz, H-2'), 7.14 (1H, d, J = 4.1 Hz, H-6'), 
6.88 (1H, d, J = 8.4 Hz, H-3'), 6.07 (2H, s, 6,7-(OCH2O)), 3.91 (3H, s, 
6-OCH3). ESI-MS for C17H12O7: m/z = 351.17 [M+Na]+ (calcd. 351.2627 
for C17H12NaO7+)
nigricin 4'-O-β-D-glucopyranoside (10): 1H NMR (300 MHz, 
CD3OD) δ: 8.04 (1H, s, H-2), 7.43 (2H, d, J = 8.5 Hz, H-2' and H-6'), 
7.14 (2H, d, J = 8.5 Hz, H-3' and H-5'), 6.75 (1H, br s, H-8), 6.10 (2H, 
s, 6,7-(OCH2O)), 4.95 (1H, d, J = 6.8 Hz, H-1''), 4.04 (3H, s, 5-OCH3), 
3.92-3.48 (overlapped sugar signals). ESI-MS for C22H20O11: m/z = 
474.68 [M+H]+ (calcd. 475.4221 for C22H21O11+); m/z = 496.63 [M+Na]+ 
(calcd. 497.4038 for C22H20NaO11+); m/z = 512.60 [M+K]+ (calcd. 
513.5125 for C22H20KO11+).
irisolidone 7-O-β-D-glucopyranoside (11): 1H NMR (300 MHz, 
CD3OD) δ: 8.21 (1H, s, H-2), 7.50 (2H, d, J = 8.4 Hz, H-2' and H-6'), 
7.00 (2H, d, J = 8.4 Hz, H-3' and H-5'), 6.88 (1H, br s, H-8), 5.10 (1H, 
d, J = 7.3 Hz, H-1''), 3.89 (3H, s, 6-OCH3), 3.83 (3H, s, 4'-OCH3), 3.80-
3.35 (overlapped sugar signals). ESI-MS for C23H24O11: m/z = 499.16 
[M+Na]+ (calcd. 499.4198 for C23H24NaO11+).
iridin (12): 1H NMR (300 MHz, CD3OD) δ: 8.23 (1H, s, H-2), 7.00 
(1H, br s, H-2'), 6.88 (2H, br s, H-6'), 6.73 (1H, s, H-8), 5.10 (1H, d, J = 
7.1 Hz, H-1''), 3.89 (3H, s, 5'-OCH3), 3.88 (3H, s, 6-OCH3), 3.82 (3H, s, 
4'-OCH3), 3.74-3.41 (overlapped sugar signals). ESI-MS for C24H26O13: 
m/z = 545.15 [M+Na]+ (calcd. 545.4452 for C24H26NaO13+); m/z = 561.12 
[M+K]+ (calcd. 561.5537 for C24H26KO13+).
irilone 4'-O-β-D-glucopyranoside (13): 1H NMR (300 MHz, 
CD3OD) δ: 8.19 (1H, s, H-2), 7.51 (2H, d, J = 8.3 Hz, H-2' and H-6'), 
7.17 (2H, d, J = 8.3 Hz, H-3' and H-5'), 7.07 (1H, s, H-8), 6.11 (2H, s, 
6,7-(OCH2O)), 5.10 (1H, d, J = 7.1 Hz, H-1''), 3.74-3.41 (overlapped 
sugar signals). ESI-MS for C22H20O11: m/z = 483.12 [M+Na]+ (calcd. 
483.3774 for C22H20NaO11+); m/z = 499.19 [M+K]+ (calcd. 499.4859 for 
C22H20KO11+).
tectoridin (14): 1H NMR (300 MHz, CD3OD) δ: 8.09 (1H, s, H-2), 
7.49 (2H, d, J = 8.1 Hz, H-2' and H-6'), 7.17 (2H, d, J = 8.1 Hz, H-3' and 
H-5'), 6.74 (1H, br s, H-8), 5.10 (1H, d, J = 7.1 Hz, H-1''), 3.86 (3H, s, 
6-OCH3), 3.74-3.42 (overlapped sugar signals). ESI-MS for C22H22O11: 
m/z = 485.21 [M+Na]+ (calcd. 405.3932 for C22H22NaO11+); m/z = 501.14 
[M+K]+ (calcd. 501.5018 for C22H22KO11+).
α-glucose (15a): 1H NMR (300 MHz, D2O) δ: 5.24 (1H, d, J = 3.2 
Hz, H-1), 3.96 (1H, m, H-6a), 3.86 (1H, m, H-5), 3.75 (1H, m, H-6b), 
3.70 (1H, m, H-3), 3.55 (1H, m, H-2), 3.41 (1H, m, H-4). ESI-MS for 
C6H12O6: m/z = 203.21 [M+Na]+ (calcd. 203.1456 for C6H12NaO6+); m/z 
= 179.07 [M-H]- (calcd. 179.1479 for C6H11O6-).
β-glucose (15b): 1H NMR (300 MHz, D2O) δ: 4.60 (1H, d, J = 8.0 
Hz, H-1), 3.91 (1H, m, H-6a), 3.73 (1H, m, H-6b), 3.51 (1H, m, H-3), 
3.49 (1H, m, H-5), 3.42 (1H, m, H-4), 3.25 (1H, m, H-2). ESI-MS for 
C6H12O6: m/z = 203.21 [M+Na]+ (calcd. 203.1456 for C6H12NaO6+); m/z 
= 179.07 [M-H]- (calcd. 179.1479 for C6H11O6-).
sucrose (16): 1H NMR (300 MHz, D2O) δ: 5.42 (1H, d, J = 3.2 Hz, 
H-1(Glc)), 4.22 (1H, d, J = 8.8 Hz, H-3'(Fru)), 4.06 (1H, m, H-4'(Fru)), 
3.90 (1H, m, H-5'(Fru)), 3.85 (1H, m, H-5(Glc)), 3.82 (4H, m, H-6(Glc) 
[33] and 1,2-distearoyl-sn-glycerol (3) [30] as a mixture in ratio 1:2:1 
from fraction 5 for the total weight of 8.9 mg; nigricin (6) [32] again in 
mixture with α-irigermanal (4) [34] in ratio 1:2 from the assembly of 
fractions 15-20 for the total weight of 10.2 mg; irigenin S (8) [25] again 
in mixture with irisflogenin (9) [17] in ratio 1:1 from the assembly of 
fractions 50-52 for the total weight of 2.6 mg; irisolidone 7-O-β-D-
glucopyranoside (11) [35] as almost pure compound from the assembly 
of fractions 72-75 for the weight of 11.9 mg; iridin (12) and irilone 
4'-O-β-D-glucopyranoside (13) [25] in mixture in ratio 1.5:1 from the 
assembly of fractions 81-83 for the total weight of 13.4 mg; again iridin 
(12) [25] but this time in mixture with tectoridin (14) [36] in ratio 2:1 
from the assembly of fractions 91-107 for the total weight of 2.7 mg.
NMR and MS data of the identified compounds
tristearoyl-sn-glycerol (1): 1H NMR (300 MHz, CDCl3) δ: 5.12 
(1H, m, H-2 (glycerol)), 4.29 (2H, dd, J = 11.8/3.9 Hz, H-1b and H-3b 
(glycerol)), 4.14 (2H, dd, J = 11.8/3.9 Hz, H-1a and H-3a (glycerol)), 
2.35 (6H, t, J = 7.5 Hz, CH2-CO2-), 1.57 (6H, m, CH2-CH2-CO2-), 1.25 
(84H, m, n-CH2), 0.86 (9H, m, CH3). ESI-MS for C57H110O6: m/z = 
912.65 [M+Na]+ (Calcd. 914.4695 for C57H110NaO6+).
1-margaroyl-2-lauroyl-3-palmitoyl-sn-glycerol (2): 1H NMR (300 
MHz, CDCl3) δ: 5.10 (1H, m, H-2 (glycerol)), 4.25 (2H, dd, J = 11.5/3.7 
Hz, H-1b and H-3b (glycerol)), 4.12 (2H, dd, J = 11.5/3.7 Hz, H-1a and 
H-3a (glycerol)), 2.32 (6H, br t, CH2-CO2-), 1.57 (6H, m, CH2-CH2-
CO2-), 1.29 (66H, m, n-CH2), 0.88 (9H, m, CH3). ESI-MS for C46H88O6: 
m/z = 759.27 [M+Na]+ (Calcd. 760.1771 for C46H88NaO6+).
1,2-distearoyl-sn-glycerol: 1H NMR (300 MHz, CDCl3) 1H NMR 
(300 MHz, CDCl3) δ: 5.11 (1H, m, H-2 (glycerol)), 4.25 (1H, dd, J 
= 11.8/4.2 Hz, H-1b (glycerol)), 4.12 (1H, dd, J = 11.8/4.2 Hz, H-1a 
(glycerol)), 3.81 (1H, m, H-3a (glycerol)), 3.68 (1H, m, H-3b (glycerol)), 
2.35 (4H, br t, CH2-CO2-), 1.57 (4H, m, CH2-CH2-CO2-), 1.29 (56H, 
m, n-CH2), 0.88 (6H, m, CH3). ESI-MS for C39H76O5: m/z = 647.16 
[M+Na]+ (Calcd. 648.0075 for C39H76NaO5+).
α-irigermanal (4): 1H NMR (300 MHz, CDCl3) δ: 10.18 (1H, br s, 
H-1), 5.34 (1H, m, H-20), 4.96 (1H, t, J = 7.0 Hz, H-14), 3.61 (2H, t, J = 
6.2 Hz, H-3), 3.31 (1H, d, J = 10.1 Hz, H-6), 2.55 (3H, br s, H-25), 2.40 – 
2.29 (m, 1H), 1.84 (3H, s, H-29), 1.53 (3H, s, H-28), 1.16 (3H, s, H-26), 
1.09 (3H, s, H-24), 0.87 (3H, s, 1H-27), 0.82 (3H, d, J = 6.7 Hz, H-31), 
0.61 (3H, s, H-30), 2.2-1.0 remaining overlapped signals. ESI-MS for 
C31H53O3: m/z = 495.41 [M+Na]+ (Calcd. 495.7325 for C31H53NaO3+). 
irisolidone (5): 1H NMR (300 MHz, CDCl3) δ: 7.87 (1H, s, H-2), 
7.45 (2H, d, J = 8.5 Hz, H-2' and H-6'), 6.98 (2H, d, J = 8.5 Hz, H-3' and 
H-5'), 6.52 (1H, br s, H-8), 4.03 (3H, s, 6-OCH3), 3.84 (3H, s, 4'-OCH3). 
ESI-MS for C17H14O6: m/z = 315.10 [M+H]+ (calcd. 315.2974 for 
C17H15O6+); m/z = 337.09 [M+Na]+ (calcd. 337.2792 for C17H14NaO6+); 
m/z = 353.06 [M+K]+ (calcd. 353.3878 for C17H14KO6+); m/z = 651.19 
[2M+Na]+ (calcd. 651.5687 for C34H28NaO12+).
(6): 1H NMR (300 MHz, CDCl3) δ: 7.86 (1H, s, H-2), 7.39 (2H, d, 
J = 8.2 Hz, H-2' and H-6'), 6.90 (2H, d, J = 8.2 Hz, H-3' and H-5'), 6.52 
(1H, br s, H-8), 6.07 (2H, s, 6,7-(OCH2O)), 4.09 (3H, s, 5-OCH3). ESI-
MS for C17H12O6: m/z = 313.09 [M+H]+ (calcd. 313.2815 for C17H13O6+); 
m/z = 335.06 [M+Na]+ (calcd. 335.2633 for C17H12NaO6+); m/z = 351.05 
[M+K]+ (calcd. 351.1719 for C17H12NaO6+)
irigenin (7): 1H NMR (300 MHz, CDCl3) δ: 7.88 (1H, s, H-2), 
6.70 (2H, d, J = 2.9 Hz, H-2' and H-6'), 6.52 (1H, s, H-8), 4.03 (3H, 
s, 6-OCH3), 3.92 (3H, s, 5'-OCH3), 3.90 (3H, s, 4'-OCH3). ESI-MS for 
C18H16O8: m/z = 383.10 [M+Na]+ (calcd. 383.3046 for C18H16NaO8+)
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and H-6'(Fru)), 3.79 (1H, m, H-3(Glc)), 3.69 (2H, s, H-1'(Fru)), 3.59 
(1H, m, H-2(Glc)), 3.48 (1H, m, H-4(Glc)). ESI-MS for C12H22O11: m/z 
= 365.17 [M+Na]+ (calcd. 365.2862 for C12H22NaO11+); m/z = 341.29 
[M-H]- (calcd. 341.2885 for C12H21O11-).
raffinose (17): 1H NMR (300 MHz, D2O) δ: 5.45 (1H, d, J = 3.2 
Hz, H-1(Glc)), 5.01 (1H, d, J = 3.8 Hz, H-1''(Gal)), 4.22 (1H, d, J = 
8.8 Hz, H-3'(Fru)), 4.06 (1H, m, H-4'(Fru)), 4.04 (2H, m, H-6a(Glc) 
and H-4''(Gal)), 3.95 (1H, m, H-5''(Gal)), 3.90 (2H, m, H-5'(Fru) 
and H-3''(Gal)), 3.85 (1H, m, H-5(Glc)), 3.82 (2H, m, H-6'(Fru) and 
H-2''(Gal)), 3.79 (3H, m, H-3(Glc) and H-6''(Gal)), 3.70 (1H, m, 
H-6b(Glc), 3.69 (2H, s, H-1'(Fru)), 3.59 (1H, m, H-2(Glc)), 3.48 (1H, 
m, H-4(Glc)). ESI-MS for C18H32O16: m/z = 527.42 [M+Na]+ (calcd. 
527.4268 for C18H32NaO16+); m/z = 503.28 [M-H]- (calcd. 503.4291 for 
C18H31NaO11-).
lactic acid (18): 1H NMR (300 MHz, D2O) δ: 4.13 (1H, m, H-α), 
1.32 (3H, d, J = 4.6 Hz, CH3). ESI-MS for C3H6O3: m/z = 89.02 [M-H]- 
(calcd. 89.0700 for C3H5O3-).
phenylalanine (19): 1H NMR (300 MHz, D2O) δ: 7.37 (2H, m, H-3 
and H-5), 7.32 (1H, m, H-4), 7.28 (2H, m, H-2 and H-6), H-α (1H) 
and H-β (2H) are overlapped with carbohydrate resonances. ESI-MS 
for C9H11NO2: m/z = 164.10 [M-H]- (calcd. 164.1812 for C9H10NO2-).
isoleucine (20): 1H NMR (300 MHz, D2O) δ: 1.95 (1H, m, H-β), 1.52 
(1H, m, H-γ'), 1.23 (1H, m, H-γ), 1.08 (3H, m, δ'-CH3), 0.93 (3H, m, 
δ-CH3), H-α (1H) is overlapped with carbohydrate resonances. ESI-MS 
for C6H13NO2: m/z = 130.33 [M-H]- (calcd. 130.1650 for C6H12NO2-).
valine (21): 1H NMR (300 MHz, D2O) δ: 2.15 (1H, m, H-β), 1.04 
(3H, d, J = 8.3 Hz, γ′-CH3), 0.97 (3H, d, J = 8.3 Hz, δ-CH3), H-α (1H) is 
overlapped with carbohydrate resonances. ESI-MS for C5H11NO2: m/z 
= 116.07 [M-H]- (calcd. 116.1464 for C5H10NO2-).
Results and Discussion
The phytochemical analysis performed on a sample of the 
ethanolic dried extract of I. marsica roots allowed the isolation and 
the identification of twenty compounds in total. In detail, these were: 
tristearoyl-sn-glycerol (1), 1-margaroyl-2-lauroyl-3-palmitoyl-sn-
glycerol (2), 1,2-distearoyl-sn-glycerol (3), α-irigermanal (4), irisolidone 
(5), nigricin (6), irigenin (7), irigenin S (8), irisflogenin (9), nigricin 
4'-O-β-D-glucopyranoside (10), irisolidone 7-O-β-D-glucopyranoside 
(11), iridin (12), irilone 4'-O-β-D-glucopyranoside (13), tectoridin (14), 
glucose (15), sucrose (16), raffinose (17), lactic acid (18), phenylalanine 
(19), isoleucine (20) and valine (21) (Figure 2).
These compounds belong to six different classes of natural 
compounds such as glycerides (compounds 1-3), triterpenoids 
(compound 4), isoflavones (compounds 5-14), sugars (compounds 15-
17), organic acids (compound 18), amino acids (compounds 19-21).
To the best of our knowledge, all these compounds represent new 
phytochemicals for the species and present a great relevance under 
three aspects: chemotaxonomy, pharmacology, nutrition. Triglycerides 
tristearoyl-sn-glycerol (1) and 1-margaroyl-2-lauroyl-3-palmitoyl-
sn-glycerol (2) and diglyceride 1,2-distearoyl-sn-glycerol (3) are 
constituted by saturated fatty acids chains at different number of carbon 
atoms. Only compound (2) presents one chain with an odd number of 
carbons while all the other chains have an even number of carbons. 
All these compounds present several nutraceutical properties in spite 
of what it’s known and said about compounds constituted by saturated 
fatty acids. Indeed, these fatty acids are responsible of these activities. 
In compounds (1) and (3), stearic acid represents the only fatty acid 
present respectively, in triplicate and in duplicate, in their structures. 
It exerts hypocholesterolemic effects [37] and does not increase the 
total risk of cardiovascular diseases [38]. Even better it seems to present 
some beneficial effects on several measures of thrombosis [38]. For 
these reasons, tristearoyl-sn-glycerol (1) and 1,2-distearoyl-sn-glycerol 
Figure 2: Chemical structures of the compounds identified in I. marsica roots.
O
O
O
O
O
O
tristearoyl-sn-glycerol (1)
O
O
O
O
O
O
1-margaroyl-2-lauroyl-3-palmitoyl-sn-glycerol (2)
OH
O
O
O
O
1,2-distearoyl-sn-glycerol (3)
O
OOR1
O
O
OR2
R3
R1 = CH3, R2 = R3 = H: nigricin (6)
R1 = R2 = H, R3 = OCH3: irisflogenin (9)
R1 = CH3, R2 = Glc, R3 = H: nigricin 4'-O-β-D-glucopyranoside (10)
R1 = R3 = H, R2 = Glc: irilone 4'-O-β-D-glucopyranoside (13)
O
OOH
R1O
H3CO
R4
OR3
R2
R1 = R2 = R4 = H, R3 = CH3: irisolidone (5)
R1 = H, R2 = OH, R3 = CH3, R4 = OCH3: irigenin (7)
R1 = R3 = CH3, R2 = OH, R4 = OCH3: irigenin S (8)
R1 = Glc, R2 = R4 = H, R3 = CH3: irisolidone 7-O-β-D-glucopyranoside (11)
R1 = Glc, R2 = OH, R3 = CH3, R4 = OCH3: iridin (12)
R1 = Glc, R2 = R3 = R4 = H: tectoridin (14)
O
HO
OH
OH
OH
OH
glucose (15)
O
HOOH
OH
OH
OO
HO OH
HO
OH
sucrose (16)
OHC
OH
α-irigermanal (4)
H2N COOH
R
H
R = CH2-phenyl: phenylalanine (19)
R = CH(CH3)CH2CH3: isoleucine (20) 
R = CH(CH3)2: valine (21)
O
OHO
OH
OH
OO
HO OH
HO
OH
raffinose (17)
O
OHOH
HO
HO
1
2
4 356
7
8
9
10
1'
6'
2'
3'
4'
5'
HO
1
2
3
4
56
7
8
9
10
1'
2' 3'
4'
5'
6'
1
14
20
2
3
4
5
6
7
8
9
1011
12
13
15
16
17
18
19
21
22
23
24
25
26
27
28
29
30
31
Citation: Venditti A, Frezza C, Rai R, Sciubba F, Cecco MD, et al.  (2017) Isoflavones and Other Compounds from the Roots of Iris marsica I. Ricci E 
Colas. Collected from Majella National Park, Italy. Med Chem (Los Angeles) 7: 787-794. doi: 10.4172/2161-0444.1000430
Med Chem (Los Angeles), an open access journal
ISSN: 2161-0444 Volume 7(2): 787-794 (2017) - 791
(3) which are, indeed, supposed to have very similar properties, 
might represent beneficial compounds. The same discussion can be 
made for 1-margaroyl-2-lauroyl-3-palmitoyl-sn-glycerol (2), too. In 
fact, margaric acid, lauric acid and palmitic acid which constitute the 
structure of this compound, have important nutraceutical properties 
as well. In particular, margaric acid exerts a potent protective action 
against type-2 diabetes [39]. At its own time, lauric acid has antibacterial 
[40], antiviral [41] and strong cytotoxic [42] activities and, moreover, is 
able to decrease the ratio between total cholesterol and HDL cholesterol 
on which it, actually, acts [43]. Lastly, palmitic acid displays antioxidant 
and selective cytotoxic properties [44]. In the end, also this compound 
seems to be a beneficial one. 
α-irigermanal (4) is the only terpenoid in general evidenced in the 
sample during this study. By the way, it is not a new phytochemical for 
the genus even if it seems to be specific to one only species, I. germanica 
L., where it has been reported several times before [34,45,46]. Thus, 
this is the first time that this compound was identified in another Iris 
species. From the pharmacological point of view, α-irigermanal (4) 
exerts a good anti-tumor activity [47]. It is also noteworthy to underline 
that (4) is the precursor of α-irone, via the α-dihydroirone intermediate 
[34,48], which is one of the violet scent-carrying 6-methylionone 
formed upon storage in I. germanica roots. On this base, also the roots 
of the I. marsica may be a potential source of aromatic principles for 
the preparation of perfumes and cosmetics with the fragrance of sweet 
violet.
Also irisolidone (5) is not a novelty phytochemical for the genus 
and just like the previous compound, represents a quite rare compound. 
In fact, its presence seems to be restricted to two specific Iris species i.e., 
I. germanica L. without differentiating the geographical provenience of 
the plant [17,49] and I. kashmiriana Baker [50]. With this phytochemical 
study, it was shown that there is a third species in which it could be 
found and this is I. marsica I. Ricci and Colas. This situation might 
make irisolidone (5) a important chemotaxonomic marker at specific 
level. Moreover, it possesses many interesting biological activities and, 
in particular, these are the antioxidant, the antibacterial, the antiviral, 
the hepatoprotective, the neuroprotective and the antitumor ones 
[17,51-55]. Lastly, it has a specific property in the nutraceutical field 
because it is able to lower the levels of total cholesterol in the serum [56] 
thus proving to be a compound with double beneficial effects on health.
Nigricin (6), also known as irisolone, represents a well spread 
compound in the Iris genus, instead. In fact, it has been evidenced 
before in several species such as I. imbricata Lindl. [57], I. germanica 
L. [58], I. nigricans Dinsm. [32], I. pallida Lam. [33] and I. susiana L. 
[59]. From the pharmacological point of view, this compound does not 
exert as many properties as all the other isoflavones but these are very 
relevant and peculiar. In particular, it can be used to treat osteoporosis, 
distal renal tubular acidosis [60] and inflammations [61] but also as a 
slight antioxidant [62].
Also irigenin (7) does not represent a new compound for the genus 
where it has been reported several times like for example in I. germanica 
L., I. dichotoma Pall., I. tectorum Maxim. [63], I. kashmiriana Baker [64], 
I. pallida Lam. [33] and I. florentina L. [65]. Under the pharmacological 
profile, this compound is able to exert a strong anti-inflammatory 
action acting on prostaglandin E2 [66] and a real inhibitory effect on 
cytochrome P450 against the outbreak of tumor forms in different parts 
of the human body [17,64]. 
Irigenin S (8) represents, chemically, a derivative of irigenin (7) with 
one more methoxy group in the position 7 of the structure to replace 
the original hydroxy group. This compound is not very common among 
all the Iris species and in fact its presence seems to be limited to only I. 
germanica L. [25,49]. This is the first time, for what we know, that it is 
reported in another species. From the pharmacological point of view, 
irigenin S (8) showed a moderate antioxidant activity [49].
Unlike the previous compound, irisflogenin (9) or iriflogenin is a 
quite widespread isoflavone in the Iris genus. This has been evidenced 
in several species such as I. potaninii Maxim. [67], I. germanica L. [17], I. 
florentina L. [68] and I. pallida Lam. [33]. In the pharmacological field, 
this compound is well known to exhibit one only but very important 
effect which is linked to cancer both as chemopreventive [17] and as 
drug [69]. 
Nigricin 4'-O-β-D-glucopyranoside (10), better known with the 
common name of germanaism B, is also not new in the genus. In 
particular, this compound is well reported in I. germanica L. where its 
presence has been massively evidenced in spite of the growth area of 
the plant [27,58,61]. Anyway, this compound has been also found in 
other Iris species such as I. leptophylla Lingelsh. ex H. Limpr. [70] and 
I. pseudopumila Tineo [71]. This compound has one only demonstrated 
pharmacological activity which is the cytotoxic one [72] and also with a 
discrete efficacy thus making it a very important isoflavone even if with 
this peculiarity.
On the other hand, irisolidone 7-O-β-D-glucopyranoside (11) 
seems to be a quite rare compound in the genus just like its aglycone 
compound. In fact, its presence has been evidenced only in particular 
species such as I. germanica L. [58] and I. imbricata Lindl. [57]. Yet, 
unlike its aglycone compound, this shows only two pharmacological 
effects which are the antitumor [17] and the radical scavenger ones [63].
Iridin (12) is, in practice, the main glycosidic isoflavone of the 
entire Iris genus so that it is considered to be its chemosystematic 
marker for excellence. Indeed, its presence within the genus is very 
common and comprises most of the existent nominal species like, for 
example, I. germanica L. [25], I. unguicularis Poir., I. dichotoma Pall., 
I. florentina L. [63], I. kumasnensis Wall. [73] and I. milesii Baker ex 
Foster [74]. This compound presents two main pharmacological 
properties i.e., antioxidant and a-amylase inhibitor thus preventing 
the insurgence of pancreatitis [48]. Nevertheless, iridin (12) has several 
nutraceutical activities. In fact, it exerts a very strong diuretic effect [63] 
and, moreover, it is a very efficient intestinal stimulant and a perfect 
cholagogue [75]. 
On the contrary, irilone 4'-O-β-D-glucopyranoside (13) represents 
another glycosidic isoflavone with a rare distribution in the Iris genus 
although it is not a new compound for it. In fact, it has been reported 
in several plants of I. germanica L. coming from different areas of the 
world [25,27,58], thus being a specific chemotaxonomic marker for 
this species. Outside this particular species, this compound has been 
evidenced only in I. pseudopumila Tineo [75] and now also in I. marsica 
I. Ricci and Colas. Irilone 4'-O-β-D-glucopyranoside (13) presents some 
outstanding pharmacological activities such as the antiproliferative 
[76], the antioxidant and mainly the anti-inflammatory ones [25]. 
Tectoridin (14) is not a new compound for the Iris genus, too. Its 
presence has been mainly detected in I. tectorum Maxim. [63] but recent 
and old studies have also reported it in other species such as I. dichotoma 
Pall. [63] and I. germanica L. [77]. From the pharmacological point of 
view, this compound shows several different medicinal properties i.e., 
antioxidant [36], anti-inflammatory, antiproliferative, antineoplastic 
[63], antiallergic, anti-platelet [78], hepato and neuroprotective [79,80]. 
Moreover, it’s able to lower the level of glucose in the blood [36] 
presenting also a nutritional value.
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The presence of compounds from (4) to (14) is important also 
under the nutraceutical aspect for what concerns their nature. In fact, 
consumption of isoflavonoids in general has been demontrated to really 
reduce the risk of cardiovascular diseases and of cancer outbreak [81]. 
Glucose (15), sucrose (16) and raffinose (17) are respectively a 
monosaccharidic, a disaccharidic and, lastly, a trisaccharidic sugar. 
The glucosidic unit is present in the structures of all these compounds, 
the fructosidic unit is present in both compounds (16) and (17) while 
the galactosidic unit is present only in compound (17). Anyway, all of 
them present similar nutraceutical properties. In particular, they are 
essential for several metabolomic processes and, in controlled quantity, 
are promoters of several health-beneficial effects. In fact, glucose (15) 
favors brain activity and can be used to treat hypoglycemia. Sucrose 
(16) displays, instead, a preservative and an antioxidant effect [82]. 
Lastly, raffinose (17) is able to reduce calories in excess. 
Lactic acid (18) is also important in the nutraceutical field. Under 
the chemical aspect, it is one of the simplest organic acid with one 
carboxyl and one alcoholic functional group and these are responsible of 
its activities. In detail, these are mainly the disinfectant, keratolytic and 
preservative ones. Above all, the latter property makes it so essential 
because it’s able to reduce the loss of nutritional value of foods in which 
it has been added. 
Lastly, phenylalanine (19), isoleucine (20) and valine (21) are, 
probably, the most relevant compounds identified in this species 
for what concerns their nutraceutical effects. First of all, these are 
essential amino acids which means that they must be supplied to our 
organism through nutrition. As second thing, phenylalanine (19) is 
used to treat  depression [83], attention deficit-hyperactivity disorder 
(ADHD) [84], and Parkinson's disease [85]. Moreover, isoleucine (20) 
is able to increase endurance and heal muscle tissues and valine (21) is 
fundamental for hematopoetic stem cell self-renewal [86].
Conclusions
From the chemotaxonomic point of view, in general, Iris marsica 
I. Ricci e Colas. seems to be very similar to I. germanica L. In addition 
to this, the presence of all the identified compounds in this sample 
provides a phytochemical rationale for the employment of also this 
species in the ethno-pharmacological field due to the several medicinal 
properties that these compound are able to exert. Lastly, all of these 
compounds have also nutraceutical value. So, we hope this species 
may be widely cultivated, in the future, for ethno-pharmacological, 
cosmetic and nutraceutical aims since it is a rare and protected species 
and cannot be collected on the wild.
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